The field has pivoted to multimarker analysis to increase the reliability and sensitivity of CEA’s diagnostic and prognostic value, including immune population ratios, cytokines, or other cancer antigens, with some improvement in predicting recurrence or disease presence[137-140]. The gene discussed is CEACAM5; the disease is cancer.